<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on September 22, 2026 at 11:18 AM by All in One SEO v5.0.1.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Tue, 22 Sep 2026 06:33:01 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/teva-study-examines-treatment-selection-in-schizophrenia/]]></guid>
			<link><![CDATA[https://cgxpwire.com/teva-study-examines-treatment-selection-in-schizophrenia/]]></link>
			<title>Teva Study Examines Treatment Selection in Schizophrenia</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 06:33:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/teva-highlights-new-uzedy-data-in-schizophrenia-care/]]></guid>
			<link><![CDATA[https://cgxpwire.com/teva-highlights-new-uzedy-data-in-schizophrenia-care/]]></link>
			<title>Teva Highlights New UZEDY Data in Schizophrenia Care</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 04:19:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/antengene-advances-atg-022-into-phase-iii-gastric-cancer-study/]]></guid>
			<link><![CDATA[https://cgxpwire.com/antengene-advances-atg-022-into-phase-iii-gastric-cancer-study/]]></link>
			<title>Antengene Advances ATG-022 Into Phase III Gastric Cancer Study</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 04:11:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/teva-reports-new-tev-749-olanzapine-lai-clinical-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/teva-reports-new-tev-749-olanzapine-lai-clinical-data/]]></link>
			<title>Teva Reports New TEV-749 Olanzapine LAI Clinical Data</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 04:07:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/intrabio-secures-fda-approval-for-aqneursa-in-a-t/]]></guid>
			<link><![CDATA[https://cgxpwire.com/intrabio-secures-fda-approval-for-aqneursa-in-a-t/]]></link>
			<title>IntraBio Secures FDA Approval for AQNEURSA in A-T</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:58:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/hfsa-highlights-late-breaking-heart-failure-clinical-research/]]></guid>
			<link><![CDATA[https://cgxpwire.com/hfsa-highlights-late-breaking-heart-failure-clinical-research/]]></link>
			<title>HFSA Highlights Late-Breaking Heart Failure Clinical Research</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:50:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/accro-bioscience-advances-ac-101-in-ulcerative-colitis/]]></guid>
			<link><![CDATA[https://cgxpwire.com/accro-bioscience-advances-ac-101-in-ulcerative-colitis/]]></link>
			<title>Accro Bioscience Advances AC-101 in Ulcerative Colitis</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:41:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/field-medical-reports-12-month-field-pulse-trial-results/]]></guid>
			<link><![CDATA[https://cgxpwire.com/field-medical-reports-12-month-field-pulse-trial-results/]]></link>
			<title>Field Medical Reports 12-Month Field PULSE Trial Results</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:40:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/eli-lilly-wins-fda-approval-for-inluriyo-verzenio-combination/]]></guid>
			<link><![CDATA[https://cgxpwire.com/eli-lilly-wins-fda-approval-for-inluriyo-verzenio-combination/]]></link>
			<title>Eli Lilly Wins FDA Approval for Inluriyo-Verzenio Combination</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:39:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/novartis-advances-cosentyx-for-polymyalgia-rheumatica/]]></guid>
			<link><![CDATA[https://cgxpwire.com/novartis-advances-cosentyx-for-polymyalgia-rheumatica/]]></link>
			<title>Novartis Advances Cosentyx for Polymyalgia Rheumatica</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:38:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/cardiacare-raises-seed-funding-for-cardiac-clinical-studies/]]></guid>
			<link><![CDATA[https://cgxpwire.com/cardiacare-raises-seed-funding-for-cardiac-clinical-studies/]]></link>
			<title>CardiaCare Raises Seed Funding for Cardiac Clinical Studies</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:37:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/abbvie-reports-new-real-world-vraylar-data-in-depression/]]></guid>
			<link><![CDATA[https://cgxpwire.com/abbvie-reports-new-real-world-vraylar-data-in-depression/]]></link>
			<title>AbbVie Reports New Real-World VRAYLAR Data in Depression</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:36:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/lakewood-amedex-advances-nu-3-phase-2a-clinical-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/lakewood-amedex-advances-nu-3-phase-2a-clinical-trial/]]></link>
			<title>Lakewood-Amedex Advances Nu-3 Phase 2a Clinical Trial</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:35:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/andelyn-biosciences-advances-commercial-gene-therapy-manufacturing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/andelyn-biosciences-advances-commercial-gene-therapy-manufacturing/]]></link>
			<title>Andelyn Biosciences Advances Commercial Gene Therapy Manufacturing</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:34:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/kells-gains-singapore-hsa-registration-for-ai-dental-scan/]]></guid>
			<link><![CDATA[https://cgxpwire.com/kells-gains-singapore-hsa-registration-for-ai-dental-scan/]]></link>
			<title>KELLS Gains Singapore HSA Registration for AI Dental Scan</title>
			<pubDate><![CDATA[Tue, 22 Sep 2026 03:32:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/insilico-opens-ai-toolkit-for-global-longevity-research/]]></guid>
			<link><![CDATA[https://cgxpwire.com/insilico-opens-ai-toolkit-for-global-longevity-research/]]></link>
			<title>Insilico Opens AI Toolkit for Global Longevity Research</title>
			<pubDate><![CDATA[Sat, 19 Sep 2026 05:26:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/leo-pharma-gains-fda-priority-review-for-dersimelagon/]]></guid>
			<link><![CDATA[https://cgxpwire.com/leo-pharma-gains-fda-priority-review-for-dersimelagon/]]></link>
			<title>LEO Pharma Gains FDA Priority Review for Dersimelagon</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 06:57:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/maat-pharma-advances-phoenix-after-negative-ema-opinion/]]></guid>
			<link><![CDATA[https://cgxpwire.com/maat-pharma-advances-phoenix-after-negative-ema-opinion/]]></link>
			<title>MaaT Pharma Advances PHOENIX After Negative EMA Opinion</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 06:56:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clearmind-briefs-fda-on-psychedelic-therapy-and-patient-access/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clearmind-briefs-fda-on-psychedelic-therapy-and-patient-access/]]></link>
			<title>Clearmind Briefs FDA on Psychedelic Therapy and Patient Access</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 06:47:56 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/adaptive-highlights-updated-nccn-mrd-guidance-in-multiple-myeloma-2/]]></guid>
			<link><![CDATA[https://cgxpwire.com/adaptive-highlights-updated-nccn-mrd-guidance-in-multiple-myeloma-2/]]></link>
			<title>Adaptive Highlights Updated NCCN MRD Guidance in Multiple Myeloma</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 06:44:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/telomir-publishes-telomir-zn-amd-preclinical-findings/]]></guid>
			<link><![CDATA[https://cgxpwire.com/telomir-publishes-telomir-zn-amd-preclinical-findings/]]></link>
			<title>Telomir Publishes Telomir-Zn AMD Preclinical Findings</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 06:31:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/hemab-doses-first-participant-in-hmb-003-phase-1/]]></guid>
			<link><![CDATA[https://cgxpwire.com/hemab-doses-first-participant-in-hmb-003-phase-1/]]></link>
			<title>Hemab Doses First Participant in HMB-003 Phase 1</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 06:30:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/capricor-to-present-deramiocel-hope-3-data-at-wms-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/capricor-to-present-deramiocel-hope-3-data-at-wms-2026/]]></link>
			<title>Capricor to Present Deramiocel HOPE-3 Data at WMS 2026</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 06:22:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/inductive-bio-launches-beacon-2-for-ai-drug-discovery/]]></guid>
			<link><![CDATA[https://cgxpwire.com/inductive-bio-launches-beacon-2-for-ai-drug-discovery/]]></link>
			<title>Inductive Bio Launches Beacon-2 for AI Drug Discovery</title>
			<pubDate><![CDATA[Sat, 19 Sep 2026 05:18:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/lisata-acquires-marea-in-225m-cardioendocrine-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/lisata-acquires-marea-in-225m-cardioendocrine-deal/]]></link>
			<title>Lisata Acquires Marea in $225M Cardioendocrine Deal</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 06:06:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mira-advances-ketamir-2-toward-phase-2a-in-cipn/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mira-advances-ketamir-2-toward-phase-2a-in-cipn/]]></link>
			<title>MIRA Advances Ketamir-2 Toward Phase 2a in CIPN</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 05:59:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/treace-reports-five-year-align3d-lapiplasty-outcomes/]]></guid>
			<link><![CDATA[https://cgxpwire.com/treace-reports-five-year-align3d-lapiplasty-outcomes/]]></link>
			<title>Treace Reports Five-Year ALIGN3D Lapiplasty Outcomes</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 05:46:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biogen-reports-positive-pediatric-empaveli-data-in-c3g/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biogen-reports-positive-pediatric-empaveli-data-in-c3g/]]></link>
			<title>Biogen Reports Positive Pediatric EMPAVELI Data in C3G</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 05:39:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/avacta-achieves-clinical-proof-of-mechanism-for-ava6103/]]></guid>
			<link><![CDATA[https://cgxpwire.com/avacta-achieves-clinical-proof-of-mechanism-for-ava6103/]]></link>
			<title>Avacta Achieves Clinical Proof of Mechanism for AVA6103</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 05:35:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/leo-pharma-gains-positive-chmp-opinion-for-anzupgo/]]></guid>
			<link><![CDATA[https://cgxpwire.com/leo-pharma-gains-positive-chmp-opinion-for-anzupgo/]]></link>
			<title>LEO Pharma Gains Positive CHMP Opinion for Anzupgo</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 05:32:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/novo-nordisk-sogroya-gains-positive-chmp-opinion-in-europe/]]></guid>
			<link><![CDATA[https://cgxpwire.com/novo-nordisk-sogroya-gains-positive-chmp-opinion-in-europe/]]></link>
			<title>Novo Nordisk Sogroya Gains Positive CHMP Opinion in Europe</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 04:09:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/johnson-johnson-tecvayli-gains-positive-chmp-opinion/]]></guid>
			<link><![CDATA[https://cgxpwire.com/johnson-johnson-tecvayli-gains-positive-chmp-opinion/]]></link>
			<title>Johnson &amp; Johnson TECVAYLI Gains Positive CHMP Opinion</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 04:08:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/roche-ocrevus-gains-chmp-support-for-pediatric-ms-patients/]]></guid>
			<link><![CDATA[https://cgxpwire.com/roche-ocrevus-gains-chmp-support-for-pediatric-ms-patients/]]></link>
			<title>Roche Ocrevus Gains CHMP Support for Pediatric MS Patients</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 04:03:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/zbeats-receives-fda-clearance-for-zbpro-diagnostic-v2-0/]]></guid>
			<link><![CDATA[https://cgxpwire.com/zbeats-receives-fda-clearance-for-zbpro-diagnostic-v2-0/]]></link>
			<title>ZBeats Receives FDA Clearance for ZBPro Diagnostic v2.0</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:54:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/olatec-therapeutics-adds-parkinsons-disease-experts/]]></guid>
			<link><![CDATA[https://cgxpwire.com/olatec-therapeutics-adds-parkinsons-disease-experts/]]></link>
			<title>Olatec Therapeutics Adds Parkinson’s Disease Experts</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:44:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/astellas-padcev-and-keytruda-gain-positive-chmp-opinion/]]></guid>
			<link><![CDATA[https://cgxpwire.com/astellas-padcev-and-keytruda-gain-positive-chmp-opinion/]]></link>
			<title>Astellas PADCEV and Keytruda Gain Positive CHMP Opinion</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:36:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/skincure-oncology-reports-higher-skin-cancer-incidence/]]></guid>
			<link><![CDATA[https://cgxpwire.com/skincure-oncology-reports-higher-skin-cancer-incidence/]]></link>
			<title>SkinCure Oncology Reports Higher Skin Cancer Incidence</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:31:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/ultragenyx-wins-fda-approval-for-fayuvi-gene-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/ultragenyx-wins-fda-approval-for-fayuvi-gene-therapy/]]></link>
			<title>Ultragenyx Wins FDA Approval for FAYUVI Gene Therapy</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:30:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/co-diagnostics-joins-who-consultation-on-global-diagnostics/]]></guid>
			<link><![CDATA[https://cgxpwire.com/co-diagnostics-joins-who-consultation-on-global-diagnostics/]]></link>
			<title>Co-Diagnostics Joins WHO Consultation on Global Diagnostics</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:29:55 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/avenda-health-brings-ai-prostate-cancer-mapping-to-arizona/]]></guid>
			<link><![CDATA[https://cgxpwire.com/avenda-health-brings-ai-prostate-cancer-mapping-to-arizona/]]></link>
			<title>Avenda Health Brings AI Prostate Cancer Mapping to Arizona</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:29:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/array-behavioral-care-launches-rapid-care-for-urgent-needs/]]></guid>
			<link><![CDATA[https://cgxpwire.com/array-behavioral-care-launches-rapid-care-for-urgent-needs/]]></link>
			<title>Array Behavioral Care Launches Rapid Care for Urgent Needs</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:28:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/cnd-life-sciences-opens-new-innovation-lab-in-scottsdale/]]></guid>
			<link><![CDATA[https://cgxpwire.com/cnd-life-sciences-opens-new-innovation-lab-in-scottsdale/]]></link>
			<title>CND Life Sciences Opens New Innovation Lab in Scottsdale</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:28:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/enable-biosciences-gains-brazil-approval-for-t1d-test/]]></guid>
			<link><![CDATA[https://cgxpwire.com/enable-biosciences-gains-brazil-approval-for-t1d-test/]]></link>
			<title>Enable Biosciences Gains Brazil Approval for T1D Test</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:27:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/onkos-surgical-expands-nanocept-access-for-total-femur-care/]]></guid>
			<link><![CDATA[https://cgxpwire.com/onkos-surgical-expands-nanocept-access-for-total-femur-care/]]></link>
			<title>Onkos Surgical Expands NanoCept Access for Total Femur Care</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:24:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/1st-biotherapeutics-and-sk-biopharma-license-parkinsons-drug/]]></guid>
			<link><![CDATA[https://cgxpwire.com/1st-biotherapeutics-and-sk-biopharma-license-parkinsons-drug/]]></link>
			<title>1ST Biotherapeutics and SK Biopharma License Parkinson&#8217;s Drug</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 03:23:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/insilico-medicine-advances-ai-designed-btk-cancer-drugs/]]></guid>
			<link><![CDATA[https://cgxpwire.com/insilico-medicine-advances-ai-designed-btk-cancer-drugs/]]></link>
			<title>Insilico Medicine Advances AI-Designed BTK Cancer Drugs</title>
			<pubDate><![CDATA[Sat, 19 Sep 2026 05:12:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/novo-nordisk-gains-positive-chmp-opinion-for-frehemgo/]]></guid>
			<link><![CDATA[https://cgxpwire.com/novo-nordisk-gains-positive-chmp-opinion-for-frehemgo/]]></link>
			<title>Novo Nordisk Gains Positive CHMP Opinion for FREHEMGO</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 05:55:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/dariohealth-expands-ai-care-to-1-5-million-lives/]]></guid>
			<link><![CDATA[https://cgxpwire.com/dariohealth-expands-ai-care-to-1-5-million-lives/]]></link>
			<title>DarioHealth Expands AI Care to 1.5 Million Lives</title>
			<pubDate><![CDATA[Sat, 19 Sep 2026 05:01:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/nuvation-bio-ibtrozi-label-updated-with-long-term-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/nuvation-bio-ibtrozi-label-updated-with-long-term-data/]]></link>
			<title>Nuvation Bio IBTROZI Label Updated With Long-Term Data</title>
			<pubDate><![CDATA[Sat, 19 Sep 2026 04:56:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/roche-opens-boston-innovation-center-for-cvrm-research/]]></guid>
			<link><![CDATA[https://cgxpwire.com/roche-opens-boston-innovation-center-for-cvrm-research/]]></link>
			<title>Roche Opens Boston Innovation Center for CVRM Research</title>
			<pubDate><![CDATA[Mon, 21 Sep 2026 05:51:33 +0000]]></pubDate>
		</item>
				</channel>
</rss>
